Notes - Consolidated Statement Of Income

Fuji Pharma Co.,Ltd. - Filing #7364276

Concept 2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2021-10-01 to
2022-09-30
Notes - Consolidated statement of income
Notes - Consolidated statement of income
Notes regarding write-downs of inventories
Write-downs of inventories
-127,000,000 JPY
91,000,000 JPY
Research and development expenses included in general and administrative expenses and manufacturing costs for period
Research and development expenses included in general and administrative expenses and manufacturing costs for period
3,184,000,000 JPY
2,485,000,000 JPY
Notes regarding loss on disposal of property, plant and equipment

Talk to a Data Expert

Have a question? We'll get back to you promptly.